Paid ₹23.5L Mahindra XUV 7XO: steering issues + rear noise within 5 mins of delivery on 21st Oct & on Oct 26: signs of possible prior bodywork. 2 proof videos attached. Complaint #CF2700208193; no update. I reject repairs and demand a full refund. @anandmahindra@anishshah21
Before you tell Indians to stay in India, look at what we are living through in Mumbai.
I live in Sion Kamghar Society, Sion East. Families are still inside this building. Look at the stairs we have to use. Look at the rubble around our homes.
Our redevelopment involves Puri Developers. Residents are demanding an investigation into alleged coercion by the developer and the society committee.
Our lift does not work. Residents say attempts to repair it are being blocked. Imagine carrying water and groceries up these broken stairs or needing medical help.
We depend on water tankers because we are not receiving BMC water. Residents say the building has been represented as unoccupied.
WE ARE STILL HERE. These are our homes.
Domestic workers have been stopped from coming upstairs. Grocery deliveries and even medicines have reportedly been obstructed. Recently, dead fish were dumped across the floors. We want those responsible identified and held accountable.
How much must everyday life deteriorate before a family gives in and leaves?
Wings A–D were demolished after being classified C1. Residents report that around half the affected families are without transit rent amid disagreements over redevelopment terms. Some have sold their flats under financial pressure.
Residents also allege that E Wing flats, many belonging to committee members, were vacated before the A–D demolition and before the IOD was obtained. Utilities were disconnected, and dismantling work left dust and debris.
Now residents of F Wing approximately 12 years old and, according to residents, not classified C1 are being pressured to vacate.
We are Jain and Hindu families. Our faith, our homes and our dignity deserve respect. Nobody should have to endure these conditions.
There have been repeated police visits. Yet we are still living like this. We are taking our fight to the High Court, but we need water and safe access TODAY.
To the Chief Minister, Municipal Commissioner, Police Commissioner, elected representatives, @Shivsenaofc and @Cockroachisback : please come here. Meet the families still living inside. See these conditions for yourselves.
We need an urgent inspection, restoration of water, safe access, lift repairs and an independent inquiry into residents’ complaints.
A family should be able to refuse unacceptable redevelopment terms without fearing that daily life will become unbearable.
This is the reality behind the word “redevelopment” for us.
Photos attached. Videos and supporting records below. Please share so our complaints are finally heard.
@Dev_Fadnavis@CMOMaharashtra@mieknathshinde@AshwiniBhide@MHFlatWelfare@mybmc@CPMumbaiPolice@MumbaiPolice@narendramodi@PMOIndia@ShivSena@ShivSenaUBT_@Suhelseth
#RedevelopmentScam #Sion #Mumbai #BMC #corruptcommittee #BJP
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
https://t.co/Ye9CVzr8qU